Table 2 Drug-related adverse events reported during the entire treatment period (All patients, N = 28)
AE category | G 0 | G 1 | G 2 | G 3 | G 4 | Total G ≥ 1 | Total G ≥ 3 | ||
|---|---|---|---|---|---|---|---|---|---|
Blood And Lymphatic System Disorders | 0 | 4 | 9 | 12 | 3 | 28 | 100.00% | 15 | 53.57% |
Anemia | 24 | 1 | 3 | 0 | 0 | 4 | 14.30% | 0 | 0.00% |
Platelet Count Decreased | 27 | 0 | 0 | 1 | 0 | 1 | 3.60% | 1 | 3.60% |
Neutropenia | 16 | 3 | 6 | 3 | 0 | 12 | 43.86% | 3 | 10.71% |
Febrile Neutropenia | 26 | 0 | 0 | 1 | 1 | 2 | 7.10% | 2 | 7.10% |
Lymphocyte Count Decreased | 0 | 6 | 10 | 10 | 2 | 28 | 100.00% | 12 | 43.86% |
Gastrointestinal Disorders | 15 | 7 | 6 | 0 | 0 | 13 | 46.40% | 0 | 0.00% |
Abdominal Pain | 26 | 1 | 1 | 0 | 0 | 2 | 7.10% | 0 | 0.00% |
Diarrhea | 23 | 2 | 3 | 0 | 0 | 5 | 17.90% | 0 | 0.00% |
Nausea | 21 | 5 | 2 | 0 | 0 | 7 | 25.00% | 0 | 0.00% |
Stomatitis | 27 | 1 | 0 | 0 | 0 | 1 | 3.60% | 0 | 0.00% |
Vomiting | 26 | 2 | 0 | 0 | 0 | 2 | 7.10% | 0 | 0.00% |
General Disorders | 13 | 7 | 6 | 2 | 0 | 15 | 53.60% | 2 | 7.10% |
Fatigue | 13 | 7 | 6 | 2 | 0 | 15 | 53.60% | 2 | 7.10% |
Metabolism And Nutrition Disorders | 23 | 3 | 2 | 0 | 0 | 5 | 17.90% | 0 | 0.00% |
Anorexia | 25 | 2 | 1 | 0 | 0 | 3 | 10.70% | 0 | 0.00% |
Hypoalbuminemia | 27 | 0 | 1 | 0 | 0 | 1 | 3.60% | 0 | 0.00% |
Weight Loss | 27 | 1 | 0 | 0 | 0 | 1 | 3.60% | 0 | 0.00% |
Nervous System Disorders | 15 | 9 | 3 | 1 | 0 | 13 | 46.43% | 1 | 3.60% |
Dizziness | 27 | 0 | 1 | 0 | 0 | 1 | 3.60% | 0 | 0.00% |
Dysgeusia | 26 | 2 | 0 | 0 | 0 | 2 | 7.10% | 0 | 0.00% |
Peripheral Sensory/Motor Neuropathy* | 16 | 8 | 3 | 1 | 0 | 12 | 43.86% | 1 | 3.60% |
Renal And Urinary Disorders | 26 | 1 | 1 | 0 | 0 | 2 | 7.10% | 0 | 0.00% |
Hematuria | 26 | 1 | 1 | 0 | 0 | 2 | 7.10% | 0 | 0.00% |
Respiratory, Thoracic And Mediastinal Disorders | 24 | 3 | 1 | 0 | 0 | 4 | 14.30% | 0 | 0.00% |
Dyspnea | 26 | 1 | 1 | 0 | 0 | 2 | 7.10% | 0 | 0.00% |
Epistaxis | 26 | 2 | 0 | 0 | 0 | 2 | 7.10% | 0 | 0.00% |
Skin And Subcutaneous Tissue Disorders | 14 | 7 | 7 | 0 | 0 | 14 | 50.00% | 0 | 0.00% |
Alopecia | 14 | 7 | 7 | 0 | 0 | 14 | 50.00% | 0 | 0.00% |
Dry Skin | 26 | 2 | 0 | 0 | 0 | 2 | 7.10% | 0 | 0.00% |